Avecho Biotechnology Limited (OEZ) Financial Statements
Avecho Biotechnology Limited Financial Overview
Avecho Biotechnology Limited's market cap is currently $33.93M. The company's EPS TTM is $-0.00; its P/E ratio is -9.33; Avecho Biotechnology Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.24M | $ 1.13M | $ 473.55K | $ 1.13M | $ 793.60K |
| Gross Profit | $ 751.29K | $ 671.93K | $ -43.80K | $ 793.12K | $ 507.94K |
| Operating Income | $ -6.00M | $ -4.96M | $ -4.59M | $ -3.06M | $ -4.55M |
| EBITDA | $ -5.87M | $ -2.92M | $ -3.24M | $ -2.11M | $ -2.98M |
| Net Income | $ -4.42M | $ -3.12M | $ -3.44M | $ -2.34M | $ -3.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.66M | $ 2.37M | $ 5.50M | $ 1.47M | $ 3.26M |
| Total Assets | $ 7.11M | $ 5.00M | $ 7.32M | $ 3.35M | $ 5.25M |
| Total Debt | $ 14.47K | $ 1.08M | $ 175.15K | $ 246.07K | $ 93.91K |
| Net Debt | $ -4.65M | $ -1.30M | $ -5.33M | $ -1.22M | $ -3.17M |
| Total Liabilities | $ 5.55M | $ 1.73M | $ 941.54K | $ 920.66K | $ 709.36K |
| Stockholders' Equity | $ 1.56M | $ 3.27M | $ 6.38M | $ 2.42M | $ 4.54M |
| Cash Flow | |||||
| Free Cash Flow | $ 1.10M | $ -3.97M | $ -3.18M | $ -1.72M | $ -3.30M |
| Operating Cash Flow | $ 1.10M | $ -3.97M | $ -3.18M | $ -1.67M | $ -3.10M |
| Investing Cash Flow | $ 0.00 | $ -15.73K | $ 0.00 | $ -53.12K | $ -202.82K |
| Financing Cash Flow | $ 1.19M | $ 854.59K | $ 7.22M | $ -78.22K | $ 4.69M |
Currency in AUD